Utilities Healthcare Sector

Ardelyx

Market Cap: US$928.3m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Spyre Therapeutics

Market Cap: US$916.2m

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Arcus Biosciences

Market Cap: US$906.4m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

Pharvaris

Market Cap: US$902.4m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

Intellia Therapeutics

Market Cap: US$880.5m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

Avadel Pharmaceuticals

Market Cap: US$871.6m

Operates as a biopharmaceutical company in the United States.

HealthStream

Market Cap: US$869.7m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

AMN Healthcare Services

Market Cap: US$868.7m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Niagen Bioscience

Market Cap: US$864.4m

Operates as a bioscience company engages in developing healthy aging products.

SI-BONE

Market Cap: US$843.3m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

CureVac

Market Cap: US$837.6m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CorMedix

Market Cap: US$832.9m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Enliven Therapeutics

Market Cap: US$827.3m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Zymeworks

Market Cap: US$816.0m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Geron

Market Cap: US$808.9m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Bicara Therapeutics

Market Cap: US$789.1m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Xeris Biopharma Holdings

Market Cap: US$781.6m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Syndax Pharmaceuticals

Market Cap: US$778.7m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Nuvation Bio

Market Cap: US$769.0m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

WELL Health Technologies

Market Cap: CA$1.1b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

LENZ Therapeutics

Market Cap: US$754.6m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Praxis Precision Medicines

Market Cap: US$754.1m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

uniQure

Market Cap: US$750.1m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Nurix Therapeutics

Market Cap: US$728.8m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Veradigm

Market Cap: US$713.3m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

Anavex Life Sciences

Market Cap: US$710.3m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

Embecta

Market Cap: US$702.5m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

Immunome

Market Cap: US$701.3m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Rocket Pharmaceuticals

Market Cap: US$700.3m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Akebia Therapeutics

Market Cap: US$685.5m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

IRADIMED

Market Cap: US$685.5m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

GH Research

Market Cap: US$681.1m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Nika Pharmaceuticals

Market Cap: US$672.8m

Engages in the development and distribution of various pharmaceutical products.

Mesa Laboratories

Market Cap: US$665.2m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.